重大事件
即時報告
8-K
2026-06-01
Jade Biosciences 提交8-K報告 附投資者簡報披露業務最新進展
AI 繁中摘要
Jade Biosciences, Inc. 於2026年6月1日向SEC提交了一份8-K現行報告 📄，報告日期同為2026年6月1日。
申報項目包括：
- Item 7.01：法規FD披露（Regulation FD Disclosure）
- Item 8.01：其他事件
- Item 9.01：財務報表及附件
作為一家專注於製藥製劑（SIC 2834）的生物科技公司，Jade Biosciences 在本次8-K中主要透過附件EX-99.1提供了一份投資者簡報（附有多張圖表），內容很可能涉及公司最新業務進展、臨床試驗數據或戰略更新。不過，申報文件本身並未披露具體財務數字或業績指引。
對投資者而言，此8-K屬於合規性披露，重點在於附件中的非公開資訊（FD），投資者應仔細查閱EX-99.1以了解潛在重大事件。由於無直接財務影響數字，短期市場反應將取決於簡報內容的驚喜程度。
展開英文正文
EDGAR Filing Documents for 0001193125-26-249763 SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001193125-26-249763 Filing Date 2026-06-01 Accepted 2026-06-01 07:55:09 Documents 36 Period of Report 2026-06-01 Items Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits Interactive Data Document Format Files Seq Description Document Type Size 1 8-K d124589d8k.htm iXBRL 8-K 49721 2 EX-99.1 d124589dex991.htm EX-99.1 36346 6 GRAPHIC g124589ex99_1s10g1.jpg GRAPHIC 76476 7 GRAPHIC g124589ex99_1s11g1.jpg GRAPHIC 65361 8 GRAPHIC g124589ex99_1s12g1.jpg GRAPHIC 102994 9 GRAPHIC g124589ex99_1s13g1.jpg GRAPHIC 120705 10 GRAPHIC g124589ex99_1s14g1.jpg GRAPHIC 99845 11 GRAPHIC g124589ex99_1s15g1.jpg GRAPHIC 100274 12 GRAPHIC g124589ex99_1s16g1.jpg GRAPHIC 106584 13 GRAPHIC g124589ex99_1s17g1.jpg GRAPHIC 75672 14 GRAPHIC g124589ex99_1s18g1.jpg GRAPHIC 38956 15 GRAPHIC g124589ex99_1s19g1.jpg GRAPHIC 110174 16 GRAPHIC g124589ex99_1s1g1.jpg GRAPHIC 63285 17 GRAPHIC g124589ex99_1s20g1.jpg GRAPHIC 72580 18 GRAPHIC g124589ex99_1s21g1.jpg GRAPHIC 92632 19 GRAPHIC g124589ex99_1s22g1.jpg GRAPHIC 52742 20 GRAPHIC g124589ex99_1s2g1.jpg GRAPHIC 228218 21 GRAPHIC g124589ex99_1s3g1.jpg GRAPHIC 127714 22 GRAPHIC g124589ex99_1s4g1.jpg GRAPHIC 100526 23 GRAPHIC g124589ex99_1s5g1.jpg GRAPHIC 74809 24 GRAPHIC g124589ex99_1s6g1.jpg GRAPHIC 92023 25 GRAPHIC g124589ex99_1s7g1.jpg GRAPHIC 92887 26 GRAPHIC g124589ex99_1s8g1.jpg GRAPHIC 102331 27 GRAPHIC g124589ex99_1s9g1.jpg GRAPHIC 39639 28 GRAPHIC g124589g0530144810720.jpg GRAPHIC 67460 29 GRAPHIC g124589imgg01.jpg GRAPHIC 78309 Complete submission text file 0001193125-26-249763.txt 3415300 Data Files Seq Description Document Type Size 3 XBRL TAXONOMY EXTENSION SCHEMA jbio-20260601.xsd EX-101.SCH 3174 4 XBRL TAXONOMY EXTENSION LABEL LINKBASE jbio-20260601_lab.xml EX-101.LAB 19498 5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE jbio-20260601_pre.xml EX-101.PRE 12152 40 EXTRACTED XBRL INSTANCE DOCUMENT d124589d8k_htm.xml XML 3943 Mailing Address 221 CRESCENT ST. BUILDING 23, SUITE 105 WALTHAM MA 02453 Business Address 221 CRESCENT ST. BUILDING 23, SUITE 105 WALTHAM MA 02453 (781) 312-3013 Jade Biosciences, Inc. (Filer) CIK: 0001798749 (see all company filings) EIN.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-40544 | Film No.: 261047199 SIC: 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)